Hopes for male contraception

Lancet

Volumn 365, Issue 9459, 2005, Pages 554-556

  Nieschlag, Eberhard ^a   Henke, Alexander ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE;

CONTRACEPTION; DEMOGRAPHY; DEVELOPING COUNTRY; ECONOMIC ASPECT; EPIDIDYMIS; HUMAN; IMMUNIZATION; IMMUNOCONTRACEPTION; IMMUNOPATHOLOGY; MALE FERTILITY; MALE GENITAL SYSTEM; MEDICAL RESEARCH; NONHUMAN; NOTE; ORAL CONTRACEPTION; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 13844275422     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70774-1     Document Type: Note

References (15)

1. Martin CW, Anderson RA, Cheng L, et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod. 15:2000;637-645
2. O'Rand MG, Widgren EE, Sivashanmugam P, et al. Reversible immunocontraception in male monkeys immunized with eppin. Science. 306:2004;1189-1190
3. Richardson RT, Sivashanmugam P, Hall SH, et al. Cloning and sequencing of human Eppin: a novel family of protease inhibitors expressed in the epididymis and testis. Gene. 270:2001;93-102
4. Thau RB, Wilson CB, Sundaram K, et al. Long-term immunization against the β-subunit of ovine luteinizing hormone (oLHβ) has no adverse effects on pituitary function in rhesus monkeys. Am J Reprod Immunol Microbiol. 15:1987;92-98
5. Moudgal NR, Jeyakumar M, Krishnamurthy HN, Sridhar S, Krishnamurthy H, Martin F. Development of a male contraceptive vaccine - a perspective. Hum Reprod Update. 3:1997;335-346
6. d'Arcangues C, Griffin DP, von Hertzen H, Islam MQ, Mbizvo MK. Development of improved and new methods of fertility regulation. Department of Reproductive Health and Research of the WHO: annual technical report. Geneva: WHO. 2000:1999;109-135
7. Waites GM. Development of methods of male contraception: impact of the World Health Organization Task Force. Fertil Steril. 80:2003;1-15
8. Nieschlag E. Reasons for abandoning immunization against FSH as an approach to male fertility regulation. Zatuchni GI, Goldsmith A, Spieler JM, Sciarra. Male contraception: advances and future prospects. 1986;395-400 Harper & Row, Philadelphia
9. Nieschlag E, Kamischke A, Behre HM. Hormonal male contraception. Nieschlag E, Behre HM. Testosterone - action, deficiency, substitution. 3rd edn:2004;685-714 Cambridge University Press, CambridgeWorld Health Organisation Task Force on Methods for the Regulation of Male Fertility
10. Jo X. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet. 336:1990;955-959
11. Kamischke A, Nieschlag E. Progress towards hormonal male contraception. Trends Pharmacol Sci. 25:2004;49-57
12. Nieschlag E, Behre HM, Engelmann U. Male contribution to contraception. Nieschlag E, Behre HM. Andrology: male reproductive health and dysfunction. 2nd edn:2001;399-418 Springer, Heidelberg
13. Nieschlag E. Sixth summit meeting on hormonal male contraception consensus: recommendations for regulatory approval for hormonal male contraception. Int J Androl. 25:2002;375
14. CONRAD. http://www.conrad.org (accessed Feb 8, 2005).
15. Diczfalusy E, Fathalla M, Habenicht UF, Stock G. The AMPPA network as a successful model for public-private or private-private partnership. Mol Cell Endocrinol. 216:2004;1-4